Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP229866.RAlnRFHVzmZ7OcUw9C641K90lo0R9XJYw-iF2k45GCpXg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP229866.RAlnRFHVzmZ7OcUw9C641K90lo0R9XJYw-iF2k45GCpXg130_assertion type Assertion NP229866.RAlnRFHVzmZ7OcUw9C641K90lo0R9XJYw-iF2k45GCpXg130_head.
- NP229866.RAlnRFHVzmZ7OcUw9C641K90lo0R9XJYw-iF2k45GCpXg130_assertion description "[KLK2/3-expressing CTCs are common in men with CRPC and bone metastases but are rare in patients with metastases diagnosed only in soft tissues and patients with localized cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP229866.RAlnRFHVzmZ7OcUw9C641K90lo0R9XJYw-iF2k45GCpXg130_provenance.
- NP229866.RAlnRFHVzmZ7OcUw9C641K90lo0R9XJYw-iF2k45GCpXg130_assertion evidence source_evidence_literature NP229866.RAlnRFHVzmZ7OcUw9C641K90lo0R9XJYw-iF2k45GCpXg130_provenance.
- NP229866.RAlnRFHVzmZ7OcUw9C641K90lo0R9XJYw-iF2k45GCpXg130_assertion SIO_000772 19233911 NP229866.RAlnRFHVzmZ7OcUw9C641K90lo0R9XJYw-iF2k45GCpXg130_provenance.
- NP229866.RAlnRFHVzmZ7OcUw9C641K90lo0R9XJYw-iF2k45GCpXg130_assertion wasDerivedFrom befree-20140225 NP229866.RAlnRFHVzmZ7OcUw9C641K90lo0R9XJYw-iF2k45GCpXg130_provenance.
- NP229866.RAlnRFHVzmZ7OcUw9C641K90lo0R9XJYw-iF2k45GCpXg130_assertion wasGeneratedBy ECO_0000203 NP229866.RAlnRFHVzmZ7OcUw9C641K90lo0R9XJYw-iF2k45GCpXg130_provenance.